Paclitaxel
FDA Approved: * January 25, 2002Pharm Company: * BAKER NORTON
Category: Cancer
Paclitaxel (PTX), sold under the brand name Taxol among others, is a chemotherapy medication used to treat a number of types of cancer.[3] This includes ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer.[3] It is administered by intravenous injection.[3] There is also an albumin-bound formulation.[3] Common side effects include hair loss, bone marrow suppressio... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Paclitaxel 100 mg/16.7ml Intravenous Injection
NDC: 0069-0076
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Paclitaxel 300 mg/50ml Intravenous Injection
NDC: 0069-0078
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Paclitaxel 30 mg/5ml Intravenous Injection
NDC: 0069-0079
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Paclitaxel 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Suspension
NDC: 0517-4300
Labeler:
American Regent, Inc.
Paclitaxel 6 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-3213
Labeler:
Teva Parenteral Medicines, Inc.
Paclitaxel 6 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-3216
Labeler:
Teva Parenteral Medicines, Inc.
Paclitaxel 6 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-3217
Labeler:
Teva Parenteral Medicines, Inc.
Paclitaxel 6 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-3218
Labeler:
Teva Parenteral Medicines, Inc.
Paclitaxel 6 mg/ml Intravenous Injection, Solution
NDC: 0703-4764
Labeler:
Teva Parenteral Medicines, Inc.
Paclitaxel 6 mg/ml Intravenous Injection, Solution
NDC: 0703-4766
Labeler:
Teva Parenteral Medicines, Inc.
